Advertisement

Picture EBD Group Global Partnering Four Events One Price 650x80

News > All

Please find below news from the Benelux countries (Belgium, Luxembourg and The Netherlands) as well as about organisations from these countries.

Total search results: 1530 | Ordered by Date (descending)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
VectorY B.V.. (6/15/21). "Press Release: VectorY Raises €31 Million in Seed Financing to Develop Next-Generation Gene Therapies Aimed at Muscular and CNS Disorders". Amsterdam. 2021-06-15
iTeos Therapeutics Inc.. (6/14/21). "Press Release: iTeos Therapeutics and GSK Announce Development and Commercialisation Collaboration for EOS-448, an anti-TIGIT Monoclonal Antibody, Enabling Novel Next-generation Immuno-oncology Combinations". Gosselie 2021-06-14
Atai Life Sciences B.V.. (6/11/21). "Press Release: Atai Life Sciences Announces Launch of Initial Public Offering". Berlin. 2021-06-11
Argenx SE. (6/7/21). "Press Release: Argenx to Regain Global Rights to Cusatuzumab". Breda. 2021-06-07
Innovative Molecules GmbH. (6/7/21). "Press Release: Innovative Molecules Raises €20 Million Series A Equity Financing Round". Munich. 2021-06-07
ImaginAb, Inc.. (6/3/21). "Press Release: ImaginAb Completes $12.8 Million Financing to Accelerate Growth Plans". Los Angeles, CA & San Diego, CA. 2021-06-03
Amyl Therapeutics. (6/3/21). "Press Release: Amyl Therapeutics Closes €18.3 Million Series A Financing to Develop Novel Therapies for Amyloidosis". Liège. 2021-06-03
Gilde Healthcare Partners. (6/2/21). "Press Release: Gilde Healthcare Appoints Joep Muijrers to Lead Investments in Public Markets". Utrecht. 2021-06-02
Argenx SE. (6/1/21). "Press Release: Argenx Appoints Karl Gubitz as Chief Financial Officer". Dublin. 2021-06-01
Moderna, Inc.. (6/1/21). "Press Release: Moderna Announces New Drug Substance Production Agreement with Lonza in the Netherlands". Albstadt. 2021-06-01
Origin.Bio GmbH. (5/26/21). "Press Release: Origin.Bio Secures $15 Million Funding Led by EQT Ventures to Help Manufacturers Create a more Sustainable Future". Munich. 2021-05-26
Ziphius Vaccines N.V.. (5/25/21). "Press Release: Ziphius Vaccines Raises €29.3M in Oversubscribed Series A Financing". 2021-05-25
Numab Therapeutics AG. (5/20/21). "Press Release: Numab Therapeutics Completes Oversubscribed CHF 100 Million Series C Financing". Wädenswil (Zurich). 2021-05-20
Hummingbird Bioscience. (5/18/21). "Press Release: Hummingbird Bioscience Raises US$125 Million in Series C Financing". Singapore. 2021-05-18
Forbion Capital Partners. (5/18/21). "Press Release: Forbion Expands Team with New General Partner". Naarden. 2021-05-18
Ginkgo Bioworks Inc.. (5/17/21). "Press Release: Ginkgo Bioworks Announces Agreement to Acquire Fungal Platform Technology Company Dutch DNA". Boston, MA. 2021-05-17
Inari. (5/12/21). "Press Release: Inari Raises Over $200 Million to Unlock the Full Potential of Seed". Cambridge, MA. 2021-05-12
Droia Ventures. (5/11/21). "Press Release: Droia Ventures Raises a New Fund of EUR 220 Million to Target Genetic Diseases and Expands Leadership Team with George Golumbeski". Brussels. 2021-05-11
Gilde Healthcare Partners. (5/6/21). "Press Release: Gilde Healthcare Acquires Majority Stake in Danish Drug Development Consultancy KLIFO to Support International Growth Ambitions". Utrecht & Copenhagen. 2021-05-06
Adcendo ApS. (4/29/21). "Press Release: Adcendo Raises EUR 51 Million in Series A Financing to Advance Novel Antibody-Drug Conjugates for Treatment of Cancers". Copenhagen. 2021-04-29
CytoSmart Technologies B.V.. (4/28/21). "Press Release: CytoSmart Redefines Automated Cell Counting with a New Fluorescence Cell Counter". Eindhoven. 2021-04-28
CytoSmart Technologies B.V.. (4/28/21). "Press Release: CytoSmart Announces a U.S. Subsidiary". Eindhoven. 2021-04-28
Inivata Ltd.. (4/28/21). "Press Release: Inivata and Agendia Sign Agreement for Commercialization of RaDaR MRD Liquid Biopsy Assay in Breast Cancer". Research Triangle Park, NC, Cambridge, Irvine, CA & Amsterdam. 2021-04-28
Molecular Partners AG. (4/23/21). "Press Release: Molecular Partners Files Registration Statement for Proposed Initial Public Offering in the United States". Zürich-Schlieren. 2021-04-23
Anavo Therapeutics B.V.. (4/22/21). "Press Release: Anavo Therapeutics Launches with EUR 20 Million Seed Financing to Create Industry-Leading Pipeline of Allosteric Phosphatase Modulators". Leiden. 2021-04-22
Forbion Capital Partners. (4/20/21). "Press Release: Forbion Announces Final Close of Forbion Growth Opportunities Fund I at EUR 360 Million (USD 428 Million)". Naarden & Munich. 2021-04-20
Inari. (4/20/21). "Press Release: Dr. Sophie V. Vandebroek, Noted Tech Leader, Joins Inari Board of Directors". Cambridge, MA. 2021-04-20
Rinri Therapeutics Ltd.. (4/20/21). "Press Release: Rinri Therapeutics Raises £10 million from Existing Investors and UK Future Fund to Advance its Novel Stem Cell Therapy to Restore Hearing Loss". Sheffield. 2021-04-20
Forbion Capital Partners. (4/16/21). "Press Release: Forbion Appoints Head of Communications". Amsterdam. 2021-04-16
Lumicks Technologies B.V.. (4/16/21). "Press Release: Lumicks Raises $93 Million in Series D Financing". Amsterdam. 2021-04-16
Royal Philips. (4/8/21). "Press Release: Philips and Ibex Medical Analytics Team to Accelerate Adoption of AI-powered Digital Pathology". Amsterdam & Tel Aviv. 2021-04-08
Gyroscope Therapeutics Ltd.. (3/26/21). "Press Release: Gyroscope Therapeutics Announces $148 Million Raised in Series C Financing". London. 2021-03-26
Leyden Laboratories B.V.. (3/25/21). "Press Release: Leyden Labs to Unlock a New Generation of Preventative Medicines against Known and Future Viruses by Securing a €40 Million Series A from GV (formerly Google Ventures), F-Prime and Casdin Capital". Ams 2021-03-25
Lava Therapeutics B.V.. (3/24/21). "Press Release: Lava Therapeutics Announces Pricing of Initial Public Offering". Utrecht & Philadelphia, PA. 2021-03-24
Meatable. (3/23/21). "Press Release: Meatable Raises $47 Million Series A to Continue Scaling Trajectory and Expand its Product Portfolio with Beef". 2021-03-23
Augustine Therapeutics. (3/23/21). "Press Release: Augustine Therapeutics Awarded EUR 1.2 Million VLAIO Research Grant to Develop New Medicines for Neuromuscular Diseases". Leuven. 2021-03-23
Augustine Therapeutics. (3/19/21). "Press Release: Augustine Therapeutics Strengthens Board of Directors and Sets Up Scientific Advisory Board". Leuven. 2021-03-19
Life Sciences Partners (LSP). (3/18/21). "Press Release: LSP Announces Closing of Upsized $120 Million Nasdaq IPO of European Biotech Acquisition Corp (EBAC) Targeting European Biotech". Amsterdam. 2021-03-18
Augustine Therapeutics. (3/18/21). "Press Release: Augustine Therapeutics Appoints Sylvain Celanire as CEO to Accelerate Development of Innovative Medicines for Rare Neuromuscular Diseases". Leuven. 2021-03-18
Amphista Therapeutics Ltd.. (3/17/21). "Press Release: Amphista Therapeutics Raises $53M in Oversubscribed Series B Round to Advance Next Generation Targeted Protein Degradation Assets". Glasgow. 2021-03-17
ExeVir Bio B.V.. (3/16/21). "Press Release: ExeVir Announces Close of $50 Million / EUR42 million Series A Financing". Belgium. 2021-03-16
Lava Therapeutics B.V.. (3/15/21). "Press Release: Lava Therapeutics B.V. Appoints Edward F. Smith as Chief Financial Officer". Utrecht & Philadelphia, PA. 2021-03-15
Univercells S.A.. (3/15/21). "Press Release: Univercells, Univercells Technologies and Gamma Biosciences Announce Mathias Garny as New CEO of Univercells Technologies". Brussels. 2021-03-15
AgomAb Therapeutics N.V.. (3/10/21). "Press Release: AgomAb Therapeutics Raises $74 Million Series B to Advance Regenerative Pathway Modulators". Ghent. 2021-03-10
Sofinnova Partners. (3/3/21). "Press Release: Sofinnova Partners Closes €445M ($540M) Oversubscribed Late-stage Healthcare Crossover Fund". Paris. 2021-03-03
Royal Philips. (3/2/21). "Press Release: Shez Partovi to Succeed Jeroen Tas as Philips’ Chief Innovation & Strategy Officer". Amsterdam. 2021-03-02
Oxular Ltd.. (3/1/21). "Press Release: Oxular Raises $37 Million". Oxford. 2021-03-01
Hologic, Inc.. (3/1/21). "Press Release: Hologic Acquires European Molecular Diagnostic Company Diagenode for Approximately $159 Million". Marlborough, MA. 2021-03-01
Osborne Clarke. (2/25/21). "Press Release: Osborne Clarke Advised Delphi Genetics on Its Acquisition by Catalent". 2021-02-25
Mosa Meat B.V.. (2/23/21). "Press Release: Mosa Meat Completes $85m Series B Investment Round". Maastricht. 2021-02-23
Catalent. (2/23/21). "Press Release: Catalent to Acquire Delphi Genetics and Launch US Plasmid Manufacturing Site to Establish Global pDNA Development and Manufacturing Capabilities". Somerset, NJ & Gosselies. 2021-02-23
InteRNA Technologies B.V.. (2/16/21). "Press Release: InteRNA Technologies Announces Dosing of First Patient in First-in-Human Trial of microRNA Drug Candidate INT-1B3 in Patients with Advanced Solid Tumors". Utrecht. 2021-02-16
CureVac N.V.. (2/12/21). "Press Release: CureVac Initiates Rolling Submission with European Medicines Agency for COVID-19 Vaccine Candidate, CVnCoV". Tübingen & Boston, MA. 2021-02-12
Forbion Capital Partners. (2/10/21). "Press Release: Launch of Novel Gene Therapy Company, VectorY, to Develop Innovative Vectorized Antibodies". Amsterdam. 2021-02-10
Galapagos N.V.. (2/10/21). "Press Release: Galapagos and Gilead Discontinue ISABELA Phase 3 Trials in IPF". Foster City, CA & Mechelen. 2021-02-10
Pan Cancer T B.V.. (2/8/21). "Press Release: Onco-immunology Company Pan Cancer T Launched as Spin-off from Erasmus Medical Center". 2021-02-08
V-Bio Ventures. (2/4/21). "Press Release: First Closing of V-Bio Fund 2 Is Announced at EUR 78 Million". Ghent. 2021-02-04
Tecan Group Ltd.. (2/4/21). "Press Release: Tecan and UgenTec Partner to Offer Sample-to-result Solutions for qPCR". Männedorf. 2021-02-04
Almirall S.A.. (2/3/21). "Press Release: Almirall Announces Gianfranco Nazzi as New CEO". 2021-02-03
Hyloris Pharmaceuticals S.A.. (2/3/21). "Press Release: Hyloris Appoints Marieke Vermeersch as VP of Investor Relations and Corporate Communications". Liège. 2021-02-03
GlaxoSmithKline plc. (2/3/21). "Press Release: GSK and CureVac to Develop Next Generation mRNA COVID-19 Vaccines". London, Tübingen & Boston, MA. 2021-02-03
Nyxoah S.A.. (2/2/21). "Press Release: Nyxoah and Vanderbilt University Enter Exclusive Licensing Agreement Regarding Next Generation Neurostimulation Technologies to Treat Obstructive Sleep Apnea (OSA)". Mont-Saint-Guibert. 2021-02-02
Argen-X N.V. (Argenx). (2/2/21). "Press Release: Argenx Raises $1.0 Billion in Gross Proceeds in a Global Offering". Breda. 2021-02-02
Medigene AG. (1/28/21). "Press Release: Focus on Solid Tumors – Discontinuation of MDG1021 Development Program". Planegg-Martinsried. 2021-01-28
CureVac N.V.. (1/28/21). "Press Release: CureVac Announces Pricing of $450 million Follow-on Public Offering of Common Shares". Tübingen & Boston, MA. 2021-01-28
High-Tech Gründerfonds Management GmbH. (1/26/21). "Press Release: GeneQuine Biotherapeutics Secures more than €9 Million in Series A Financing and Non-Dilutive Funding to Advance Gene Therapy Pipeline for Musculoskeletal Diseases". 2021-01-26
CureVac N.V.. (1/25/21). "Press Release: CureVac Announces Proposed Public Offering of Common Shares". Tübingen & Boston, MA. 2021-01-25
BiondVax Pharmaceuticals Ltd.. (1/21/21). "Press Release: BiondVax Announces Appointment of Amir Reichman as New CEO". Jerusalem. 2021-01-21
Merus N.V.. (1/21/21). "Press Release: Merus Announces Pricing of Public Offering of Common Shares". Utrecht & Cambridge, MA. 2021-01-21
Life Sciences Partners (LSP). (1/20/21). "Press Release: LSP Leads EUR 21 Million Series B Funding Round in Neurent Medical". Amsterdam. 2021-01-20
Merus N.V.. (1/19/21). "Press Release: Merus N.V. Announces Proposed Public Offering of Common Shares". Utrecht & Cambridge, MA. 2021-01-19
Merus N.V.. (1/19/21). "Press Release: Lilly and Merus NV Announce Collaboration to Discover Novel T-Cell Re-Directing Bispecific Antibodies". Indianapolis, IN & Utrecht. 2021-01-19
Forbion Capital Partners. (1/19/21). "Press Release: Forbion Invests USD 2.3M in Seed Financing of CoviCept Therapeutics, Inc.". Naarden. 2021-01-19
Agilent Technologies Inc.. (1/15/21). "Press Release: Agilent Names Allison Ballmer Senior Vice President of Corporate Development". Santa Clara, CA. 2021-01-15
Thermo Fisher Scientific Inc.. (1/15/21). "Press Release: Thermo Fisher Scientific Acquires Viral Vector Manufacturing Business from Novasep". Waltham, MA & Lyon. 2021-01-15
Affimed N.V.. (1/15/21). "Press Release: Affimed Announces Closing of Public Offering of Common Shares and Full Exercise of Underwriters’ Option to Purchase Additional Shares". Heidelberg. 2021-01-15
NewAmsterdam Pharma B.V.. (1/14/21). "Press Release: NewAmsterdam Pharma Completes $196M (€160M) Series A Funding for Comprehensive Phase 3 Development Program". Naarden. 2021-01-14
UCB S.A.. (1/13/21). "Press Release: UCB Announces Launch of Nile AI, Inc., a Digital Health Company Set to Transform the Course of Epilepsy". Brussels & Atlanta, GA. 2021-01-13
Affimed N.V.. (1/12/21). "Press Release: Affimed Announces Pricing of $100,000,000 Public Offering of Common Shares". Heidelberg. 2021-01-12
Affimed N.V.. (1/12/21). "Press Release: Affimed Announces Proposed Public Offering of Common Shares". Heidelberg. 2021-01-12
Novartis AG. (1/11/21). "Press Release: Novartis Expands Oncology Pipeline with In-licensing of Tislelizumab from BeiGene". Basel. 2021-01-11
Affimed N.V.. (1/11/21). "Press Release: Affimed Announces €25 Million Debt Financing Agreement with Silicon Valley Bank". Heidelberg. 2021-01-11
Qiagen N.V.. (1/8/21). "Press Release: Qiagen Announces Appointment of New Supervisory Board Member". Venlo. 2021-01-08
CureVac N.V.. (1/7/21). "Press Release: CureVac and Bayer Join Forces on COVID-19 Vaccine Candidate CVnCoV". Berlin, Tübingen & Boston; MA. 2021-01-07
BioGeneration Ventures B.V.. (1/7/21). "Press Release: BioGeneration Ventures BGV IV Fund Closes at €140 Million". Naarden. 2021-01-07
Merus N.V.. (1/7/21). "Press Release: Merus Granted FDA Fast Track Designation of Zenocutuzumab for the Treatment of Patients with Neuregulin 1 Fusion Cancers". Utrecht & Cambridge, MA. 2021-01-07
Qiagen N.V.. (1/7/21). "Press Release: Qiagen Announces Global Distribution Agreement for the COSMIC Database from the Wellcome Sanger Institute". Redwood City, CA & Hilden. 2021-01-07
Moderna, Inc.. (1/6/21). "Press Release: European Commission Authorizes COVID-19 Vaccine Moderna in Europe". Cambridge, MA. 2021-01-06
Cristal Delivery B.V. (d/b/a Cristal Therapeutics). (1/6/21). "Press Release: Cristal Therapeutics and Intravacc Announce Strategic Collaboration to Advance Novel Vaccine Platforms". Bilthoven & Maastricht. 2021-01-06
Argenx SE. (1/6/21). "Press Release: Argenx and Zai Lab Announce Strategic Collaboration for Efgartigimod in Greater China". Breda, Shanghai & San Francisco, CA. 2021-01-06
Siemens Healthineers AG. (1/5/21). "Press Release: Siemens Healthineers Proposes Peer Schatz to Annual Shareholders' Meeting as New Supervisory Board Member". Erlangen. 2021-01-05
MiNA Therapeutics Ltd.. (1/5/21). "Press Release: MiNA Therapeutics Appoints Robin Wright as Chief Financial Officer". London. 2021-01-05
Volta Medical. (1/5/21). "Press Release: Volta Medical Raises 28 Million USD to Revolutionize Persistent AFib Ablation". Marseille. 2021-01-05
Argenx SE. (1/4/21). "Press Release: Argenx to Present at 39th Annual J.P. Morgan Healthcare Conference". Breda & Ghent. 2021-01-04
BioNTech SE. (12/21/20). "Press Release: Pfizer and BioNTech Receive Authorization in the European Union for COVID-19 Vaccine". New York, NY & Mainz. 2020-12-21
BioNTech SE. (12/21/20). "Press Release: Pfizer and BioNTech Receive CHMP Positive Opinion for their COVID-19 Vaccine". New York, NY & Mainz. 2020-12-21
Swedish Orphan Biovitrum AB. (12/21/20). "Press Release: Sobi Appoints New Head of North America Ahead of Launch Phase". 2020-12-21
Uniqure N.V.. (12/21/20). "Press Release: uniQure Announces Clinical Update on Hemophilia B Gene Therapy Program". Lexington, MA & Amsterdam. 2020-12-21
Univercells S.A.. (12/17/20). "Press Release: Univercells Holding Raises €70 Million in Series C Financing". Brussels. 2020-12-17
Galapagos N.V.. (12/15/20). "Press Release: Gilead and Galapagos Announce New Commercialization and Development Agreement for Jyseleca (filgotinib)". Foster City, CA & Mechelen. 2020-12-15
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16  next pagenext page



Advertisement

Picture [iito] Plain Stupid Simple 650x80px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture EBD Group Global Partnering Four Events One Price 650x80

» top